Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

NCT00947531 is registered in ClinicalTrials.gov with Ever Neuro Pharma GmbH as lead sponsor.

NCT NCT00947531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00947531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
Lead sponsor
Ever Neuro Pharma GmbH
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2006
Completion date
August 31, 2007
Enrollment
242 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

vascular dementia